Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study).
Published Mar 1, 2007 · C. Ballantyne, R. Weiss, T. Moccetti
The American journal of cardiology
180
Citations
2
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayRosuvastatin 40 mg combined with ezetimibe 10 mg significantly improves LDL cholesterol goals in high-risk patients compared to statin monotherapy.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.